Apoptotic Marker Analysis in Heated‐Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases
Journal of Surgical Oncology · 2026-05 · 133 (6) · 705-711
DOI: 10.1002/jso.70226 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 03.03.2026. Verfasst von Eran Nizri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery B and Laboratory of Surgical Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Hyperthermic Intraperitoneal Chemotherapy, Apoptosis, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To evaluate apoptotic markers in tumor cells from hyperthermic intraperitoneal chemotherapy (HIPEC) effluent as a biomarker of treatment effectiveness.
Background
Cytoreductive surgery (CRS) combined with HIPEC is used to treat peritoneal surface malignancies (PSM), yet no validated method exists to assess HIPEC efficacy in real time. We explored whether apoptosis in residual tumor cells present in post‐HIPEC effluent correlates with oncologic outcomes.
Methods
Forty‐four patients undergoing CRS‐HIPEC were prospectively enrolled. CD45⁻ cells were stained for Annexin‐PI by flow cytometry before and after HIPEC. The apoptotic response (Δapop) was defined as the increase in apoptosis post‐HIPEC. Clinical and procedural variables were correlated with peritoneal disease‐free survival (pDFS).
Results
Tumor histologies included colorectal (50%), appendiceal (18.2%), ovarian (15.9%), and gastric (11.4%) primaries. Complete cytoreduction was achieved in 81.8% of patients. Median Δapop = 8.5% (IQR: 0%–37%). Responders had significantly prolonged pDFS (median not reached vs. 16 months; p = 0.04). On multivariable analysis, apoptotic response remained a significant predictor of pDFS (HR = 0.22; 95% CI: 0.05–0.87; p = 0.03), independent of PCI and CCR.
Conclusions
In this pilot study, apoptotic markers in HIPEC effluent are a histology‐agnostic assay that correlates with recurrence risk. This biomarker may improve patient selection for adjuvant therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery B and Laboratory of Surgical Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel.
- Department of Surgery, Ziv Medical Center, Safed, Israel.
- Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Zitieren
APA
Nizri, E., Dranizky, Y., Lipczyc, K., Uzana, R., Ben-Yaakov, A., Nissan, A., Lahat, G., Berger, Y., & Geva, R. (2026). Apoptotic Marker Analysis in Heated‐Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases. Journal of Surgical Oncology, 133(6), 705-711. https://doi.org/10.1002/jso.70226
Vancouver
Nizri E, Dranizky Y, Lipczyc K, Uzana R, Ben-Yaakov A, Nissan A, et al. Apoptotic Marker Analysis in Heated‐Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases. Journal of Surgical Oncology. 2026;133(6):705-711. doi:10.1002/jso.70226
BibTeX
@article{Nizri2026,
author = {Nizri, Eran and Dranizky, Yuval and Lipczyc, Kelly and Uzana, Ronny and Ben-Yaakov, Almog and Nissan, Aviram and Lahat, Guy and Berger, Yaniv and Geva, Ravit},
title = {Apoptotic Marker Analysis in Heated‐Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {133},
number = {6},
pages = {705--711},
doi = {10.1002/jso.70226}
}
EUVIMED